If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

AGM Trading Update

16 Mar 2022 07:00

RNS Number : 8923E
IDOX PLC
16 March 2022
 

16 March 2022

Idox plc

("Idox" or "the Group")

 

AGM Trading update

 

Continued resilient performance

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, is pleased to issue a trading update ahead of today's Annual General Meeting (AGM) for the period 1 November 2021 to date.

 

Highlights for the period include:

 

· Continued resilient operational and financial performance, in line with the Board's expectations.

 

· Order book visibility remains strong, underpinning our confidence.

 

· The Group secured new contract wins and extensions in the period across both our Public Sector Software and Engineering Information Management businesses.

 

· Acquisitions completed in 2021 are integrating well and to plan; good line of sight over an attractive M&A pipeline.

 

· Further to the announcement dated 21 February 2022, Anoop Kang joins the Board and assumes the position of Chief Financial Officer of Idox following the conclusion of today's AGM. He is succeeding Rob Grubb who is taking up a newly created role focussed on advancing the Group's inorganic growth strategy.

 

A further trading update will be issued following the half year ending 30 April 2022.

 

David Meaden, Chief Executive Officer, said:

 

"The business is performing in line with our expectations for the half year and integration of the three businesses acquired in 2021 is on track. Whilst we are cognisant of the current geo-political uncertainties, and the challenges of recruiting talent across the industry, we are well positioned to accelerate the 'fly' phase of our journey. The Group is making good progress against its plans for 2022 and anticipates delivering further growth over the medium term."

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Edward Knight

Paul Gillam

James Smith

 

+44 (0) 20 7418 8900

MHP Communications

Reg Hoare

James Bavister

Harry Clarke

 

+ 44 (0) 203 128 8170

idox@mhpc.com

 

 

About Idox plc

For more information see Idox | Software Built on Insight (idoxgroup.com).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCGDXBBBDGDU
Date   Source Headline
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20211:08 pmRNSForm 8.3 Disclosure
16th Mar 202112:00 pmRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20219:54 amGNWForm 8.3 - Idox plc
15th Mar 20218:27 amRNSForm 8.5 (EPT/RI) IDOX Plc
15th Mar 20217:00 amRNSTotal Voting Ritghts & Rule 2.9 Announcement
12th Mar 202112:03 pmGNWForm 8.3 - [IDOX plc - 11-03-2021] - (CGWL)
12th Mar 20218:57 amRNSForm 8.5 (EPT/RI) IDOX Plc
12th Mar 20217:00 amRNSDisposal of Idox Compliance
11th Mar 20212:17 pmRNSForm 8.3 Disclosure
11th Mar 202111:38 amGNWForm 8.3 - [IDOX plc - 10-03-2021] - (CGWL)
11th Mar 20218:21 amRNSForm 8.5 (EPT/RI) IDOX Plc
10th Mar 202111:54 amGNWForm 8.3 - [IDOX plc - 09-03-2021] - (CGWL)
10th Mar 20219:46 amRNSForm 8.5 (EPT/RI)
10th Mar 20219:22 amRNSForm 8.5 (EPT/RI) IDOX Plc
9th Mar 202111:44 amGNWForm 8.3 - [IDOX plc - 08-03-2021] - (CGWL)
9th Mar 20218:44 amRNSForm 8.5 (EPT/RI) IDOX Plc
8th Mar 20214:34 pmRNSForm 8.3 - IDOX PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.